The Zacks Instruments - Scientific industry is benefiting from increasing healthcare spending, driven by an aging demography, and continued innovation in the pharma and life sciences end-markets. Higher demand for generic drugs and biosimilars is driving growth for scientific tool and apparatus providers. Industry participants like Mettler-Toledo International (MTD) and Bruker (BRKR) are gaining from the growing testing needs of newer biological drugs. Increased scrutiny of per and polyfluoroalkyl substance ...

The Nasdaq is off to a scorching start in 2024. The Nasdaq 100 Index is making new highs seemingly almost every week, and glamor stocks in fields such as artificial intelligence (AI) and semiconductors are blasting off.This has left some investors worried about a potential bubble. There are definitely some significantly overvalued Nasdaq stocks out there. However, there are still quite a few good buys within the Nasdaq today. These three Nasdaq stocks to buy, in particular, offer good entry points right now ...

Bruker Corporation (BRKR) delivered adjusted earnings per share (EPS) of 70 cents in the fourth quarter of 2023, down 5.4% year over year. The figure exceeded the Zacks Consensus Estimate by 7.7%.The adjustments include expenses related to the amortization of purchased intangibles, acquisition-related costs and restructuring costs, among others.GAAP EPS in the quarter was $1.41, surging 113.6% from the year-earlier quarter’s figure of 66 cents.For the full year, adjusted earnings were $2.58 per share, risin ...

Financial Data and Key Metrics Changes - In Q4 2023, Bruker reported revenues of $854.5 million, a 20.6% increase year-over-year, with organic revenue growth of 15.9% [9][54] - For the full year 2023, revenues increased by 17.1% to $2.96 billion, with organic growth of 14.5% [11][34] - Non-GAAP diluted EPS for Q4 2023 was $0.70, down 5.4% from $0.74 in Q4 2022, primarily due to the PhenomeX acquisition [10][59] - The company achieved a non-GAAP EPS growth of 10.3% year-over-year for 2023 [8][48] Business Line Data and Key Metrics Changes - The Scientific Instruments segment (BSI) saw 15.5% organic growth, while the best segment experienced 20.3% organic growth in Q4 2023 [9] - BioSpin Group revenue for 2023 was $799 million, growing in the teens percentage range [24] - Bruker Nano revenue reached $942 million in 2023, with high teens percentage growth [25] - The CALID group had revenue of $960 million, with strong growth driven by life science mass spectrometry [50] Market Data and Key Metrics Changes - In Q4 2023, Americas revenue grew in the teens percentage, Asia-Pacific revenue grew in the 20% range, and European revenue grew in the mid-teens percentage [32] - The EMEA region reported high single-digit percentage revenue growth year-over-year in Q4 2023 [32] Company Strategy and Development Direction - Bruker aims to achieve its fiscal year 2026 medium-term outlook for revenue and non-GAAP EPS by fiscal year 2025, driven by strong growth and strategic acquisitions [15][37] - The company is focusing on innovation in high-value solutions and ongoing portfolio transformation [27][53] - Recent acquisitions, including PhenomeX, are expected to enhance Bruker's capabilities in the post-genomic era [14][115] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for 2024, expecting organic revenue growth of 5% to 7% and non-GAAP EPS growth of 5% to 7% compared to 2023 [21][35] - The company noted that geopolitical risks, particularly related to conflicts, could impact operations but emphasized strong fundamentals in the academic and government sectors [18][117] - Management highlighted a solid backlog and bookings momentum entering 2024, indicating a positive outlook for continued growth [21][131] Other Important Information - Bruker reported a non-GAAP operating margin of 18.1% in Q4 2023, down 290 basis points year-over-year due to acquisition headwinds [58] - The company generated $205.5 million of operating cash flow in Q4 2023, with free cash flow of $174 million [57][60] - The effective tax rate for Q4 2023 was 31.3%, compared to 20.6% in the prior year [33] Q&A Session Summary Question: Can you discuss the LRP pull-forward comment and its implications for earnings growth? - Management expressed optimism about pulling forward revenue and non-GAAP EPS targets due to strong 2023 results and execution, with expectations for significant EPS growth in 2025 [39] Question: Can you unpack the margin guidance and the factors affecting it? - Management clarified that the margin guidance is impacted by the timing of the PhenomeX acquisition, which will become a tailwind in future periods [43] Question: What is the outlook for the academic market given current geopolitical conditions? - Management noted that academic government revenue growth remains strong, with solid bookings growth, despite some fluctuations in specific regions like China [68] Question: How are the recent acquisitions expected to impact profitability? - Management indicated that the recent acquisitions are profitable and will not significantly impact margins negatively [139] Question: What is the current status of backlog and its implications for future growth? - Management reported a backlog of approximately 7.5 months, which is elevated but expected to decrease over the next few years [131]

Bruker (BRKR) reported $854.5 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 20.6%. EPS of $0.70 for the same period compares to $0.74 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $830.68 million, representing a surprise of +2.87%. The company delivered an EPS surprise of +7.69%, with the consensus EPS estimate being $0.65.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Str ...

Bruker (BRKR) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.74 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this scientific equipment maker would post earnings of $0.63 per share when it actually produced earnings of $0.74, delivering a surprise of 17.46%.Over the last four quarters, the ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Bruker (BRKR) , which belongs to the Zacks Instruments - Scientific industry, could be a great candidate to consider.When looking at the last two reports, this scientific equipment maker has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 10.81%, on average, in the last two quarters.For the most recent qua ...

Investors are always looking for stocks that are poised to beat at earnings season and Bruker Corporation (BRKR) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Bruker is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good ind ...

OSAKA, Japan--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquartered in Osaka, Nanophoton offers a broad portfolio of advanced Raman microscopes, serving academic and industrial research customers, primarily in Japan. This acquisition fills a gap in Bruker’s molecular microscopy portfolio, and Bruker is looking forward to offering fast, flexible and sensitive Nanophoton Raman ...

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2023 financial results before market opening on Tuesday, February 13, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q4 2023 Earnings Webcast” hyperlink in the “Events & Presentations” section. ...